心臟血管成像设备的开发平台报告:开发阶段,市场区隔,地区·国家,法规通行证,主要企业-2022年最新版
市场调查报告书
商品编码
1097833

心臟血管成像设备的开发平台报告:开发阶段,市场区隔,地区·国家,法规通行证,主要企业-2022年最新版

Cardiovascular Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

出版日期: | 出版商: GlobalData | 英文 73 Pages | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

本报告提供心臟血管成像设备的开发中产品调查,提供主要开发中产品的明细(产品说明,专利及联盟明细,其他的开发活动等),从事开发的主要企业检讨与其开发平台计划一览,基于从开发初期阶段到核准/已发行阶段的各种开发阶段提供开发中产品的涵盖范围,针对开发中产品的进行中主要临床试验资料,市场区隔/产业上最近的开发情形等详细资讯。

目录

第1章 目录

  • 表格清单
  • 图清单

第2章 简介

  • 心臟血管成像设备概要

第3章 开发中的产品

  • 心臟血管成像设备-各开发阶段的开发中产品
  • 心臟血管成像设备-各地区的开发中产品
  • 心臟血管成像设备-各法规通行证的开发中产品
  • 心臟血管成像设备-到核准预定日前的开发中产品

第4章 心臟血管成像设备-企业正在开发的开发中产品

  • 心臟血管成像设备企业-各开发阶段的开发中产品
  • 心臟血管成像设备-各开发阶段的开发中产品

第5章 心臟血管成像设备企业与产品概要

  • Aetna Inc 企业概要
  • Beth Israel Deaconess Medical Center 企业概要
  • CardioPaint 企业概要
  • Centerline Biomedical Inc 企业概要
  • Cleveland Clinic Hospital 企业概要
  • Columbia University 企业概要
  • CorVista Health Inc 企业概要
  • Echopoint Medical Ltd 企业概要
  • Eindhoven University of Technology 企业概要
  • ElectroSonix LLC 企业概要
  • FMI Medical Systems Inc 企业概要
  • Illumasonix LLC (暂停中) 企业概要
  • Johns Hopkins University 企业概要
  • King's College London 企业概要
  • Koninklijke Philips NV 企业概要
  • Massachusetts Institute of Technology 企业概要
  • Nano4Imaging GmbH 企业概要
  • Panoramic Hengsheng (Beijing) Science and
  • Technology Co Ltd 企业概要
  • Perinatronics Medical systems Inc 企业概要
  • Philips Ultrasound, Inc. 企业概要
  • Purdue University 企业概要
  • Tribogenics, Inc. 企业概要
  • University Health Network 企业概要
  • University of Colorado 企业概要
  • University of Glasgow 企业概要
  • University of Pittsburgh 企业概要
  • Vida Medical Devices Inc 企业概要
  • Vigilant Medical Inc 企业概要

第6章 心臟血管成像设备-最近的开发

第7章 附录

  • 调查手法
  • 关于GlobalData
  • 咨询方式
  • 免责声明
Product Code: GDME1370EPD

GlobalData's Medical Devices sector report, "Cardiovascular Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Cardiovascular Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiovascular Imaging Equipment are the imaging devices that capture the images of heart to diagnose the condition of heart.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Imaging Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Imaging Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Imaging Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Cardiovascular Imaging Equipment Overview

3 Products under Development

  • 3.1 Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development
  • 3.2 Cardiovascular Imaging Equipment - Pipeline Products by Territory
  • 3.3 Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path
  • 3.4 Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date

4 Cardiovascular Imaging Equipment - Pipeline Products under Development by Companies

  • 4.1 Cardiovascular Imaging Equipment Companies - Pipeline Products by Stage of Development
  • 4.2 Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development

5 Cardiovascular Imaging Equipment Companies and Product Overview

  • 5.1 Aetna Inc Company Overview
  • 5.2 Beth Israel Deaconess Medical Center Company Overview
  • 5.3 CardioPaint Company Overview
  • 5.4 Centerline Biomedical Inc Company Overview
  • 5.5 Cleveland Clinic Hospital Company Overview
  • 5.6 Columbia University Company Overview
  • 5.7 CorVista Health Inc Company Overview
  • 5.8 Echopoint Medical Ltd Company Overview
  • 5.9 Eindhoven University of Technology Company Overview
  • 5.10 ElectroSonix LLC Company Overview
  • 5.11 FMI Medical Systems Inc Company Overview
  • 5.12 Illumasonix LLC (Inactive) Company Overview
  • 5.13 Johns Hopkins University Company Overview
  • 5.14 King's College London Company Overview
  • 5.15 Koninklijke Philips NV Company Overview
  • 5.16 Massachusetts Institute of Technology Company Overview
  • 5.17 Nano4Imaging GmbH Company Overview
  • 5.18 Panoramic Hengsheng (Beijing) Science and Technology Co Ltd Company Overview
  • 5.19 Perinatronics Medical systems Inc Company Overview
  • 5.20 Philips Ultrasound, Inc. Company Overview
  • 5.21 Purdue University Company Overview
  • 5.22 Tribogenics, Inc. Company Overview
  • 5.23 University Health Network Company Overview
  • 5.24 University of Colorado Company Overview
  • 5.25 University of Glasgow Company Overview
  • 5.26 University of Pittsburgh Company Overview
  • 5.27 Vida Medical Devices Inc Company Overview
  • 5.28 Vigilant Medical Inc Company Overview

6 Cardiovascular Imaging Equipment- Recent Developments

  • 6.1 May 10, 2022: Stereotaxis Reports 2022 First Quarter Financial Results
  • 6.2 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
  • 6.3 Apr 28, 2022: LeMaitre Q1 2022 Financial Results
  • 6.4 Apr 15, 2022: LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022
  • 6.5 Mar 30, 2022: Broncus Medical Announces Annual Results for 2021: Operating revenue for 2021 increased 234.2% year-on-year, while product development and commercialization are steadily advancing.
  • 6.6 Mar 09, 2022: Stereotaxis Announces Grand Opening of New Global Headquarters in St. Louis
  • 6.7 Mar 01, 2022: HeartFlow Announces CEO Transition
  • 6.8 Feb 24, 2022: LeMaitre Q4 2021 Financial Results
  • 6.9 Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022
  • 6.10 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
  • 6.11 Jan 03, 2022: MediBalloon expands operations and establishes mass production capabilities in Taiwan's Medeologix
  • 6.12 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
  • 6.13 Oct 28, 2021: Stereotaxis to Report Third Quarter 2021 Financial Results on November 11, 2021
  • 6.14 Oct 28, 2021: LeMaitre Q3 2021 Financial Results
  • 6.15 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
  • 6.16 Oct 19, 2021: Pivotal consensus statement for Medistim's transit time flow technology (TTFM) published in Circulation
  • 6.17 Oct 14, 2021: LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021
  • 6.18 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
  • 6.19 Aug 13, 2021: Medistim Announces Second quarter and first half financials 2021
  • 6.20 Jul 29, 2021: LeMaitre Q2 2021 Financial Results
  • 6.21 Jul 26, 2021: Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.
  • 6.22 Jul 20, 2021: Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021
  • 6.23 Jul 15, 2021: LeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021
  • 6.24 Jul 13, 2021: LeMaitre Provides Q2 2021 Update
  • 6.25 Jun 24, 2021: Peter Arduini named CEO of GE healthcare
  • 6.26 Jun 22, 2021: Angel Medical Systems Announces Brad Snow as Interim Chief Executive Officer
  • 6.27 Jun 03, 2021: GE Healthcare and the American College of Cardiology join forces to advance AI in cardiac care

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development
  • Cardiovascular Imaging Equipment - Pipeline Products by Territory
  • Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path
  • Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date
  • Cardiovascular Imaging Equipment Companies - Pipeline Products by Stage of Development
  • Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development
  • Cardiovascular Imaging Equipment - Pipeline Products by Territory
  • Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path
  • Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date